PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 50 filers reported holding PROQR THRAPEUTICS N V in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,696 | +101.4% | 9,766 | +150.9% | 0.00% | – |
| Q2 2023 | $6,305 | -79.7% | 3,892 | -90.5% | 0.00% | – |
| Q3 2022 | $31,000 | -32.6% | 41,126 | -30.5% | 0.00% | – |
| Q2 2022 | $46,000 | +21.1% | 59,176 | +40.3% | 0.00% | – |
| Q1 2022 | $38,000 | -90.5% | 42,167 | -15.8% | 0.00% | – |
| Q4 2021 | $401,000 | +5628.6% | 50,102 | +5929.1% | 0.00% | – |
| Q3 2021 | $7,000 | -93.9% | 831 | -95.1% | 0.00% | – |
| Q2 2021 | $114,000 | +225.7% | 16,898 | +196.5% | 0.00% | – |
| Q2 2020 | $35,000 | +12.9% | 5,700 | +1.4% | 0.00% | – |
| Q1 2020 | $31,000 | -90.2% | 5,620 | -82.4% | 0.00% | -100.0% |
| Q4 2019 | $316,000 | +572.3% | 31,904 | +292.9% | 0.00% | – |
| Q3 2019 | $47,000 | – | 8,120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |